McFIT “The Original” Launches International Franchising – One of Europe’s Most Recognized Fitness Brands Enters a New Era
22.1.2026 12:00:00 CET | news aktuell GmbH | Press Release
Berlin / Germany, 01/22/2026 – McFIT, a cornerstone of the European fitness landscape since 1997, is entering a new chapter in its corporate development: for the first time, the successful gym concept will be offered as an international franchise. This move paves the way for McFIT’s global franchise growth in previously untapped markets without company-owned locations.

To date, McFIT has been active exclusively with over 230 company-owned gyms across Europe (Germany, Austria, and Italy). All studios have been leased, built, and fully operated by the company. This structure will remain unchanged in existing markets. At the same time, McFIT is now pursuing an international growth strategy that complements the successful franchise model of Gold’s Gym, which has been part of the RSG Group since 2020. Gold’s Gym currently operates 58 company-owned studios worldwide alongside 507 franchise gyms.
“Over the past years, we have proven that we not only understand franchise systems, but can successfully scale them worldwide,” says Jörg Fockenberg, VP Strategy, Expansion & Franchise at the RSG Group.
“With the internationalization of McFIT as a franchise concept, we are taking the next logical step and opening our strongest European brand to new markets around the world.”
To make the McFIT concept globally accessible for franchise partners, the company developed a comprehensive package of professional franchise tools. These are designed to adapt flexibly to local conditions, ensure strong brand management and a consistent brand appearance, and provide partners with all necessary tools for smooth studio setup and daily operations. This is complemented by clearly defined processes and structures that support franchise partners from initial contact through well beyond contract signing.
“Our goal is to create a franchise system that offers partners maximum guidance, security, and efficiency – while fully leveraging McFIT’s unique brand strength,” explains Dr. Jobst Müller-Trimbusch, Co-CEO of the RSG Group. “We want to empower entrepreneurs worldwide to continue the success story of McFIT in their own countries.”
The McFIT franchise is exclusively aimed at countries in which the brand is not yet represented with company-owned gyms. This opens McFIT to a wide range of new markets and target groups. The primary focus is on recruiting master franchisees.
Further information is available at www.mcfit.com/franchise-en


Contacts
RSG Group GmbHHead OfficeRSG Group GmbH
Saarbrücker Straße 38 10405 Berlin Germany
Images
About RSG Group
With more than 4.5 million members in its studios, RSG Group is one of the world’s leading companies in the fitness industry. Founded in 1996 by Rainer Schaller and still family-owned today, RSG Group has grown into an internationally operating company. Including its franchise partners, the group employs 10,000 people at over 900 locations and is represented in more than 30 countries. Its extensive and future-oriented portfolio includes brands such as McFIT, the JOHN REED family, and Gold’s Gym. RSG Group’s mission is to continuously set new standards and remain an essential part of its customers’ active lifestyles. For more information: http://rsggroup.com/en/

Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Webasto Air Top Pro 25: a new, exceptionally quiet parking heater for campers22.10.2026 13:28:00 CEST | Press Release
Why should the camping season end just because summer is over? The colder months offer unique experiences—from skiing and snowshoeing to simply enjoying the winter landscape. To ensure your motorhome or campervan remains a comfortable retreat even in low temperatures, the right heating solution is crucial.
Polarise Launches Sovereign AI Cloud at NVIDIA GTC Berlin, Delivering Enterprise AI From Data Center to Application22.10.2026 10:00:00 CEST | Press Release
With Polarise Rise and Polarise Drive, the German AI provider extends its own European AI Factories into a full-stack sovereign cloud
Fiscal strength doesn't guarantee public goods delivery, US study finds21.10.2026 09:28:38 CEST | Press Release
New York/DNA - A newly released study of US state government performance found strong partisan and regional patterns within three pillars of governance: democratic accountability, state capacity and public goods provision. Yet, the US states’ outcomes differ in important ways from international comparisons, as the three governance dimensions show limited correlation, the researchers found. The report, “The Governance Performance of the Fifty States: The U.S. Berggruen Governance Index”, applies the research team’s “governance triangle” from past global country rankings to the 50 US states. The report has now been presented to the public at Columbia University in New York. “Unlike in the Berggruen Governance Index’s cross-national comparisons, where the three dimensions are broadly correlated, in the 50 U.S. states they often run counter to each other,” the authors conclude. “This may seem counterintuitive, as one might expect a well-governed state to finish high on all three and a poor
agineo expands partnership with ServiceNow, launches AI Control Tower as a Service20.10.2026 12:48:13 CEST | Press Release
New managed service provides transparency into the AI landscape and helps companies centrally manage AI, monitor risks and regulatory requirements, and highlight business benefits.
Grünenthal advances proprietary Nociceptin Receptor (NOP) Agonist into Phase II trial in acute pain20.10.2026 09:23:41 CEST | Press Release
Potential first-in-class, selective nociceptin receptor (NOP) agonist that aims to provide safe, effective treatment for moderate to severe acute pain. Following successful Phase I results earlier this year demonstrating an excellent safety profile, the program has now progressed to Phase II. The randomized, double-blind, double-dummy, placebo- and active controlled, 2-part Phase II trial will evaluate the safety, tolerability and efficacy of this novel NOP agonist in patients post bunionectomy surgery. Grünenthal anticipates reporting results in early 2028.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom


